Prediction of conformational changes by single mutation in the hepatitis B virus surface antigen (HBsAg) identified in HBsAg-negative blood donors.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 2998485)

Published in Virol J on November 18, 2010

Authors

Susan I Ie1, Meta D Thedja, Martono Roni, David H Muljono

Author Affiliations

1: Eijkman Institute for Molecular Biology, Jl. Diponegoro 69, Jakarta, Indonesia.

Articles cited by this

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res (1997) 665.31

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis (1997) 57.27

InterProScan--an integration platform for the signature-recognition methods in InterPro. Bioinformatics (2001) 28.35

The InterPro Database, 2003 brings increased coverage and new features. Nucleic Acids Res (2003) 24.72

The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res (2005) 21.68

I-TASSER server for protein 3D structure prediction. BMC Bioinformatics (2008) 18.28

The Protein Data Bank and structural genomics. Nucleic Acids Res (2003) 8.34

Template-based modeling and free modeling by I-TASSER in CASP7. Proteins (2007) 6.45

Vaccine-induced escape mutant of hepatitis B virus. Lancet (1990) 5.31

Ab initio modeling of small proteins by iterative TASSER simulations. BMC Biol (2007) 5.07

The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci (1988) 5.00

Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol (2008) 3.50

Progress and challenges in protein structure prediction. Curr Opin Struct Biol (2008) 3.48

Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA. Lancet (1995) 2.82

Hepatitis B virus genotypes. Vaccine (2005) 2.56

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology (1998) 1.98

Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med (1987) 1.93

Molecular epidemiology of hepatitis B virus vaccine variants in Singapore. Vaccine (1995) 1.71

Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology (2001) 1.61

A topological model for hepatitis B surface antigen. Intervirology (1992) 1.59

Effect of hepatitis B virus mutants on efficacy of vaccination. Lancet (2000) 1.58

The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat (1997) 1.58

Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant. J Clin Invest (1992) 1.48

Mapping of amino acid side chains on the surface of hepatitis B virus capsids required for envelopment and virion formation. J Virol (2003) 1.42

Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci U S A (1996) 1.32

Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis. Hepatology (1996) 1.27

Hepatitis B virus genetic diversity. J Med Virol (2006) 1.21

Reactivity of 13 in vitro expressed hepatitis B surface antigen variants in 7 commercial diagnostic assays. Hepatology (2000) 1.16

The prevalence of surface antigen variants of hepatitis B virus in Papua New Guinea, South Africa, and Sardinia. Hepatology (1997) 1.15

Effect of variation in the common "a" determinant on the antigenicity of hepatitis B surface antigen. J Med Virol (2000) 1.13

Diagnostic problems caused by HBsAg mutants-a consensus report of an expert meeting. Intervirology (2004) 1.05

Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol (2006) 1.01

Hepatitis B surface antigen escape mutant in a first time blood donor potentially missed by a routine screening assay. Clin Lab (2004) 0.99

Viral genetic variation: hepatitis B virus as a clinical example. Lancet (1993) 0.93

Occult hepatitis B in blood donors in Indonesia: altered antigenicity of the hepatitis B virus surface protein. Hepatol Int (2010) 0.90

A unique amino acid substitution, T126I, in human genotype C of hepatitis B virus S gene and its possible influence on antigenic structural change. Gene (2006) 0.87

Substitution rate of the hepatitis B virus surface gene. J Viral Hepat (2007) 0.84

Molecular characterization of envelope antigenic variants of hepatitis B virus from Spain. J Infect Dis (1994) 0.83

A novel hepatitis B virus mutant with A-to-G at nt551 in the surface antigen gene. World J Gastroenterol (2003) 0.81